Sharmila Majumdar, PhD, is a UCSF Professor and the Vice Chair of Research in the Department of Radiology and Biomedical Imaging and Professor in the Departments of Bioengineering and Therapeutic Sciences, Orthopedic Surgery at UCSF and Bioengineering at UC Berkeley. Dr. Sharmila Majumdar discusses the opportunities and challenges of rheumatoid arthritis imaging with Scott Holland, PhD, Associate Director of Medpace Imaging Core Laboratory, in this timely and relevant interview.
Dr. Majumdar and Dr. Holland discussed topics such as:
- The difference between Osteoarthritis and Rheumatoid Arthritis and do these differences influence the type of imaging we should use?
- What is the best imaging modality for RA diagnosis or progression of disease?
- With MRI, does T1, T2 or PD provide the best sensitivity and specificity for RA?
- For MRI of RA, what is the best field strength to use?
- Do you see a future for molecular imaging agents in RA or for autoimmune diseases in general?
- Would PET be relevant to imaging inflammation in RA?
- What do you see in the future for imaging in clinical trials for RA therapeutics?
Medpace has the medical leadership, autoimmune trained staff, global trial experience, and site relationships to make your study a success. Learn more about Medpace autoimmune capabilities.